In another report, a 26week treatment with the GLP1R/GIPR dual agonist LY3298176 (Tirzepatide, Eli Lilly), showed significant reduction in A1c in an incremental, dosedependent manner (4 doses from 1 mg to 15 mg, A1c reduction from 1.06% to 1.94% respectively)
The clinical translation of these trial results, which will be important for the comparison of GLP-1RAs with SGLT2 inhibitors in the treatment of patients with heart failure and a preserved ejection fraction, remains to be determined
As a result, they are increasingly used in patients with both diabetes and cardiovascular disease
At tretinoin concentrations of 0.025% and 0.1%, and retinol concentrations of 0.1% and 1%, retinoids have decades of photoaging, texture, and wrinkle data behind them
[194] Common adverse effects reported in clinical studies include gastrointestinal distress, nausea, and headaches, while more serious concerns involve elevated liver enzymes, jaundice, and systemic toxicity
Typically, patients start with one or two injections per week for four weeks and then switch to one injection a month, depending on their needs